首页 > 最新文献

Drug and alcohol review最新文献

英文 中文
Activity-Based Funding in Alcohol and Other Drug Treatment Services: Clinical Staff Perspectives and Practice Implications 酒精和其他药物治疗服务中基于活动的资助:临床工作人员的观点和实践意义。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-15 DOI: 10.1111/dar.70033
Ciara Smyth, Kaniz Fatema, kylie valentine, Raquel Lowe, Brett Ross, Eltham Cook, Gilbert Whitton

Introduction

Many drug health services receive activity-based funding (ABF), which is reliant on accurate data collection to ensure appropriate reimbursement and quality care. This article reports results of a qualitative study commissioned by NSW Health about drug health services clinical staff's experiences in meeting ABF data entry requirements.

Methods

Semi-structured interviews were conducted with drug health services clinical staff (n = 10) to investigate their experiences in meeting ABF data entry requirements.

Results

Participants identified some benefits of an ABF model, but they described many technical and conceptual barriers to complying with ABF data reporting requirements. These included making frequent data entry errors, activity categories not aligning with their interpretation of the work they did, and not always knowing what activities attracted funding.

Discussion and Conclusions

Practical measures to improve compliance include training and quality assurance opportunities, enhanced managerial and administrative support, database enhancements and increased collaboration between clinicians and technicians. Implementing these measures could result in more accurate funding for services and improve patient care.

导言:许多药物保健服务接受基于活动的供资(ABF),这依赖于准确的数据收集,以确保适当的报销和高质量的护理。本文报告了新南威尔士州卫生部委托进行的一项关于药物卫生服务临床工作人员在满足ABF数据输入要求方面的经验的定性研究的结果。方法:对10名药品卫生服务临床工作人员进行半结构化访谈,了解他们在满足ABF数据录入要求方面的经验。结果:参与者确定了ABF模型的一些好处,但是他们描述了遵守ABF数据报告要求的许多技术和概念障碍。这些包括频繁的数据输入错误,活动类别与他们对所做工作的解释不一致,以及不总是知道哪些活动吸引了资金。讨论和结论:改善依从性的实际措施包括培训和质量保证机会、加强管理和行政支持、增强数据库以及增加临床医生和技术人员之间的合作。实施这些措施可以更准确地为服务提供资金,并改善患者护理。
{"title":"Activity-Based Funding in Alcohol and Other Drug Treatment Services: Clinical Staff Perspectives and Practice Implications","authors":"Ciara Smyth,&nbsp;Kaniz Fatema,&nbsp;kylie valentine,&nbsp;Raquel Lowe,&nbsp;Brett Ross,&nbsp;Eltham Cook,&nbsp;Gilbert Whitton","doi":"10.1111/dar.70033","DOIUrl":"10.1111/dar.70033","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Many drug health services receive activity-based funding (ABF), which is reliant on accurate data collection to ensure appropriate reimbursement and quality care. This article reports results of a qualitative study commissioned by NSW Health about drug health services clinical staff's experiences in meeting ABF data entry requirements.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Semi-structured interviews were conducted with drug health services clinical staff (<i>n</i> = 10) to investigate their experiences in meeting ABF data entry requirements.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Participants identified some benefits of an ABF model, but they described many technical and conceptual barriers to complying with ABF data reporting requirements. These included making frequent data entry errors, activity categories not aligning with their interpretation of the work they did, and not always knowing what activities attracted funding.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Practical measures to improve compliance include training and quality assurance opportunities, enhanced managerial and administrative support, database enhancements and increased collaboration between clinicians and technicians. Implementing these measures could result in more accurate funding for services and improve patient care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"1932-1939"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs 丁丙诺啡依从性轨迹及其对阿片类药物过量和医疗费用的影响。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-11 DOI: 10.1111/dar.70035
Olajumoke A. Olateju, Tyler Varisco, Scott Weiner, Douglas Thornton

Introduction

Buprenorphine is effective for opioid use disorder (OUD), yet adherence remains suboptimal. This study aimed to identify adherence trajectories, explore their predictors, and assess their association with opioid overdose risk and healthcare costs.

Methods

A retrospective cohort study was conducted using the Merative MarketScan Commercial Database, which includes a nationally representative sample of individuals with private, employer-sponsored health insurance in the United States. We included adults (≥ 16 years) with OUD who initiated and completed at least 30 consecutive days of buprenorphine treatment between July 2017 and June 2019, with a 180-day follow-up. Group-based trajectory modelling identified distinct adherence patterns. Multinomial logistic regression examined predictors of adherence trajectories. A discrete-time survival model estimated the association between adherence and opioid overdose risk, while generalised linear models assessed healthcare costs. Sensitivity analyses, including E-value calculations, evaluated residual confounding.

Results

Among the 5107 individuals (median [Q1-Q3] age in years: 37 [26–47]; 3185 [62.4%] male), three distinct buprenorphine adherence trajectories were identified in the follow-up period: consistent adherence (CA, 49.5%), slow-declining adherence (SDA, 28.0%) and rapidly-declining adherence (RDA, 22.5%) trajectory groups. The mean (95% CI) time to buprenorphine discontinuation among all beneficiaries was 153 (151–155) days. Compared to the CA group, SDA and RDA groups had 2.74 (95% CI 2.71–2.77) and 3.81 (95% CI: 3.76–3.86) times higher opioid overdose risk and $13,670 (95% CI $7644–$19,695) and $19,431 (95% CI $13,632–$25,229) higher healthcare spending, respectively.

Discussion and Conclusions

Consistent adherence to buprenorphine was associated with a lower risk of opioid overdose and reduced healthcare expenditures.

丁丙诺啡对阿片类药物使用障碍(OUD)有效,但依从性仍不理想。本研究旨在确定依从性轨迹,探索其预测因素,并评估其与阿片类药物过量风险和医疗费用的关系。方法:使用Merative MarketScan商业数据库进行回顾性队列研究,该数据库包括具有全国代表性的美国私人雇主赞助的健康保险个人样本。我们纳入了在2017年7月至2019年6月期间开始并完成至少连续30天丁丙诺啡治疗的OUD成人(≥16岁),并进行了180天的随访。基于群体的轨迹模型确定了不同的依从模式。多项逻辑回归检验了依从性轨迹的预测因子。离散时间生存模型估计了依从性与阿片类药物过量风险之间的关系,而广义线性模型评估了医疗成本。敏感性分析,包括e值计算,评估残留混淆。结果:5107例患者(中位年龄[Q1-Q3]: 37岁[26-47岁],男性3185例[62.4%])在随访期间发现了三种不同的丁丙诺啡依从性轨迹:一致依从性(CA, 49.5%)、缓慢下降依从性(SDA, 28.0%)和快速下降依从性(RDA, 22.5%)轨迹组。在所有受益人中,丁丙诺啡停药的平均(95% CI)时间为153(151-155)天。与CA组相比,SDA组和RDA组的阿片类药物过量风险分别高出2.74倍(95% CI 2.71-2.77)和3.81倍(95% CI 3.76-3.86),医疗支出分别高出13,670美元(95% CI 7644- 19,695美元)和19,431美元(95% CI 13,632- 25,229美元)。讨论和结论:持续坚持丁丙诺啡与阿片类药物过量风险降低和医疗支出减少有关。
{"title":"Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs","authors":"Olajumoke A. Olateju,&nbsp;Tyler Varisco,&nbsp;Scott Weiner,&nbsp;Douglas Thornton","doi":"10.1111/dar.70035","DOIUrl":"10.1111/dar.70035","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Buprenorphine is effective for opioid use disorder (OUD), yet adherence remains suboptimal. This study aimed to identify adherence trajectories, explore their predictors, and assess their association with opioid overdose risk and healthcare costs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective cohort study was conducted using the Merative MarketScan Commercial Database, which includes a nationally representative sample of individuals with private, employer-sponsored health insurance in the United States. We included adults (≥ 16 years) with OUD who initiated and completed at least 30 consecutive days of buprenorphine treatment between July 2017 and June 2019, with a 180-day follow-up. Group-based trajectory modelling identified distinct adherence patterns. Multinomial logistic regression examined predictors of adherence trajectories. A discrete-time survival model estimated the association between adherence and opioid overdose risk, while generalised linear models assessed healthcare costs. Sensitivity analyses, including E-value calculations, evaluated residual confounding.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among the 5107 individuals (median [Q1-Q3] age in years: 37 [26–47]; 3185 [62.4%] male), three distinct buprenorphine adherence trajectories were identified in the follow-up period: consistent adherence (CA, 49.5%), slow-declining adherence (SDA, 28.0%) and rapidly-declining adherence (RDA, 22.5%) trajectory groups. The mean (95% CI) time to buprenorphine discontinuation among all beneficiaries was 153 (151–155) days. Compared to the CA group, SDA and RDA groups had 2.74 (95% CI 2.71–2.77) and 3.81 (95% CI: 3.76–3.86) times higher opioid overdose risk and $13,670 (95% CI $7644–$19,695) and $19,431 (95% CI $13,632–$25,229) higher healthcare spending, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Consistent adherence to buprenorphine was associated with a lower risk of opioid overdose and reduced healthcare expenditures.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"1907-1919"},"PeriodicalIF":2.6,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145033091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Short-Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023) 加拿大不列颠哥伦比亚省个人持有部分非法药物合法化对药物中毒的短期影响(2015-2023)。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-11 DOI: 10.1111/dar.70036
Sameer Imtiaz, Sami Aftab Abdul, Huan Jiang, Cayley Russell, Farihah Ali, Iesha Henderson, Bernard Le Foll, Tara Elton-Marshall, Brooke Kinniburgh, Jürgen Rehm

Introduction

Canada is in the midst of a crisis featuring drug poisonings. Decriminalisation of personal possession of select illegal drugs was implemented in British Columbia, Canada on 31 January 2023 as one element of a public health response to reduce drug-related harms. We evaluated the short-term impacts of decriminalisation on paramedic responses to opioid poisonings and drug poisoning deaths to detect if there were early signals of change.

Methods

We sourced population-based monthly counts of drug poisonings from the provincial emergency services provider and coroners service to compute total and sex-specific age-standardised rates per 100,000 (January 2015–December 2023 [97 months pre-decriminalisation and 11 months post-decriminalisation]). Generalised additive models in an interrupted time series design were used to evaluate the short-term impacts of decriminalisation on rates of paramedic responses to opioid poisonings and drug poisoning deaths.

Results

Decriminalisation was not associated with an immediate effect (β [95% confidence interval; CI] −0.078 [−0.318, 0.163]) or trend change (β [95% CI] −0.022 [−0.082, 0.037]) in the total rate of paramedic responses to opioid poisonings, nor was it associated with an immediate effect (β [95% CI] −0.165 [−0.477, 0.147]) or trend change (β [95% CI] −0.010 [−0.082, 0.062]) in the total rate of drug poisoning deaths. These findings were consistent after stratification by sex.

Discussion and Conclusions

Decriminalisation of select illegal drugs was not associated with significant changes in drug poisonings in the first 11 months of its implementation. However, the direction of effects was encouraging from a public health standpoint.

简介:加拿大正处于一场以药物中毒为特征的危机之中。加拿大不列颠哥伦比亚省于2023年1月31日实施了将个人拥有某些非法药物非刑事化,作为减少与毒品有关危害的公共卫生对策的一项内容。我们评估了非刑事化对护理人员对阿片类药物中毒和药物中毒死亡的反应的短期影响,以检测是否有早期变化信号。方法:我们从省级紧急服务提供者和验尸官处获取基于人口的每月药物中毒计数,以计算每10万人中总发生率和按性别划分的年龄标准化发生率(2015年1月至2023年12月[除罪前97个月和除罪后11个月])。使用中断时间序列设计中的广义加性模型来评估非刑事化对护理人员对阿片类药物中毒和药物中毒死亡的反应率的短期影响。结果:非刑事化与阿片类药物中毒总护理人员反应率的立即效果(β[95%置信区间;CI] -0.078[-0.318, 0.163])或趋势变化(β [95% CI] -0.022[-0.082, 0.037])无关,也与药物中毒总死亡率的立即效果(β [95% CI] -0.165[-0.477, 0.147])或趋势变化(β [95% CI] -0.010[-0.082, 0.062])无关。这些发现在按性别分层后是一致的。讨论和结论:在实施的前11个月,某些非法药物的非刑事化与药物中毒的重大变化无关。然而,从公共卫生的角度来看,影响的方向是令人鼓舞的。
{"title":"The Short-Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023)","authors":"Sameer Imtiaz,&nbsp;Sami Aftab Abdul,&nbsp;Huan Jiang,&nbsp;Cayley Russell,&nbsp;Farihah Ali,&nbsp;Iesha Henderson,&nbsp;Bernard Le Foll,&nbsp;Tara Elton-Marshall,&nbsp;Brooke Kinniburgh,&nbsp;Jürgen Rehm","doi":"10.1111/dar.70036","DOIUrl":"10.1111/dar.70036","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Canada is in the midst of a crisis featuring drug poisonings. Decriminalisation of personal possession of select illegal drugs was implemented in British Columbia, Canada on 31 January 2023 as one element of a public health response to reduce drug-related harms. We evaluated the short-term impacts of decriminalisation on paramedic responses to opioid poisonings and drug poisoning deaths to detect if there were early signals of change.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We sourced population-based monthly counts of drug poisonings from the provincial emergency services provider and coroners service to compute total and sex-specific age-standardised rates per 100,000 (January 2015–December 2023 [97 months pre-decriminalisation and 11 months post-decriminalisation]). Generalised additive models in an interrupted time series design were used to evaluate the short-term impacts of decriminalisation on rates of paramedic responses to opioid poisonings and drug poisoning deaths.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Decriminalisation was not associated with an immediate effect (<i>β</i> [95% confidence interval; CI] −0.078 [−0.318, 0.163]) or trend change (<i>β</i> [95% CI] −0.022 [−0.082, 0.037]) in the total rate of paramedic responses to opioid poisonings, nor was it associated with an immediate effect (<i>β</i> [95% CI] −0.165 [−0.477, 0.147]) or trend change (<i>β</i> [95% CI] −0.010 [−0.082, 0.062]) in the total rate of drug poisoning deaths. These findings were consistent after stratification by sex.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Decriminalisation of select illegal drugs was not associated with significant changes in drug poisonings in the first 11 months of its implementation. However, the direction of effects was encouraging from a public health standpoint.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"1856-1865"},"PeriodicalIF":2.6,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines 了解使用澳大利亚胎儿酒精谱系障碍诊断指南的决定因素:为新的国家临床实践指南的审查、发展和传播提供信息
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-07 DOI: 10.1111/dar.70030
Natasha Reid, Jayden Logan, Yasmine Wong, Zachary Munn, Chelsea Vanderpeet, Nicole Hayes, the Australian FASD Guidelines Consortium

Introduction

The Australian Guide to the Diagnosis of fetal alcohol spectrum disorder (FASD), developed in 2016, is currently under review. This study aimed to understand how the Guide is used in practice and identify factors influencing its implementation.

Methods

A cross-sectional online survey was conducted with Australian health practitioners involved in the assessment and diagnosis of FASD. The Clinician Guideline Determinants Questionnaire was used. Quantitative data were summarised descriptively and content analysis was applied to open-ended questions.

Results

Of 333 survey sessions, 232 participants consented and 136 completed the survey. Most respondents were paediatricians (n = 54, 37%) or psychologists (n = 49, 33%). Although most clinicians felt confident using the Guide, only 44.1% agreed it clearly described the underlying evidence, and just 21% felt it adequately reflected patient preferences. Key enablers included clear, easy-to-follow guidance (n = 45, 36.3%); ease of access (n = 18, 14.5%) and familiarity with the Guide (n = 14, 11.3%). Common barriers were lack of access to appropriate clinicians, time and cost constraints (n = 25, 24.8%); concerns about the evidence base (n = 16, 15.8%); and lack of familiarity or skills (n = 8, 7.9%).

Discussion and Conclusions

Findings highlight strong clinician engagement with the 2016 Guide but also identify areas for improvement, particularly around evidence transparency and alignment with person-centred care. By engaging with stakeholders and improving guidelines based on clinician feedback, we can improve the quality of care and support for individuals with FASD and their families.

导读:澳大利亚胎儿酒精谱系障碍诊断指南(FASD)于2016年制定,目前正在审查中。本研究旨在了解《指南》在实践中的使用情况,并确定影响其实施的因素。方法:对参与FASD评估和诊断的澳大利亚卫生从业人员进行横断面在线调查。使用临床医生指南决定因素问卷。定量数据进行描述性总结,内容分析应用于开放式问题。结果:在333次调查中,232人同意,136人完成了调查。大多数回答者是儿科医生(n = 54, 37%)或心理学家(n = 49, 33%)。尽管大多数临床医生对使用指南有信心,但只有44.1%的临床医生认为指南清楚地描述了基础证据,只有21%的临床医生认为指南充分反映了患者的偏好。关键促成因素包括清晰、易于遵循的指导(n = 45, 36.3%);易获取性(n = 18, 14.5%)和对指南的熟悉程度(n = 14, 11.3%)。常见的障碍是无法获得合适的临床医生、时间和成本限制(n = 25, 24.8%);对证据基础的担忧(n = 16, 15.8%);缺乏熟悉或技能(n = 8, 7.9%)。讨论和结论:调查结果强调了临床医生对2016年指南的积极参与,但也确定了需要改进的领域,特别是在证据透明度和与以人为本的护理相一致方面。通过与利益相关者合作,并根据临床医生的反馈改进指导方针,我们可以提高对FASD患者及其家庭的护理和支持质量。
{"title":"Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines","authors":"Natasha Reid,&nbsp;Jayden Logan,&nbsp;Yasmine Wong,&nbsp;Zachary Munn,&nbsp;Chelsea Vanderpeet,&nbsp;Nicole Hayes,&nbsp;the Australian FASD Guidelines Consortium","doi":"10.1111/dar.70030","DOIUrl":"10.1111/dar.70030","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The Australian Guide to the Diagnosis of fetal alcohol spectrum disorder (FASD), developed in 2016, is currently under review. This study aimed to understand how the Guide is used in practice and identify factors influencing its implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional online survey was conducted with Australian health practitioners involved in the assessment and diagnosis of FASD. The Clinician Guideline Determinants Questionnaire was used. Quantitative data were summarised descriptively and content analysis was applied to open-ended questions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 333 survey sessions, 232 participants consented and 136 completed the survey. Most respondents were paediatricians (<i>n</i> = 54, 37%) or psychologists (<i>n</i> = 49, 33%). Although most clinicians felt confident using the Guide, only 44.1% agreed it clearly described the underlying evidence, and just 21% felt it adequately reflected patient preferences. Key enablers included clear, easy-to-follow guidance (<i>n</i> = 45, 36.3%); ease of access (<i>n</i> = 18, 14.5%) and familiarity with the Guide (<i>n</i> = 14, 11.3%). Common barriers were lack of access to appropriate clinicians, time and cost constraints (<i>n</i> = 25, 24.8%); concerns about the evidence base (<i>n</i> = 16, 15.8%); and lack of familiarity or skills (<i>n</i> = 8, 7.9%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Findings highlight strong clinician engagement with the 2016 Guide but also identify areas for improvement, particularly around evidence transparency and alignment with person-centred care. By engaging with stakeholders and improving guidelines based on clinician feedback, we can improve the quality of care and support for individuals with FASD and their families.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2080-2090"},"PeriodicalIF":2.6,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145014229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in Australia 在澳大利亚社区门诊治疗中心开始治疗的个体中与酒精使用相关的因素。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-03 DOI: 10.1111/dar.70034
Jamie Bryant, Anthony Shakeshaft, Nicholas Lintzeris, Paul Haber, Michael Farrell, Joshua Dizon, Megan Freund

Introduction

Understanding the characteristics of individuals seeking treatment for alcohol use is essential for developing effective interventions. This study aimed to: (i) describe the characteristics of individuals accessing treatment at Australian outpatient alcohol and other drug (AOD) treatment centres; and (ii) identify characteristics associated with more harmful alcohol use at treatment commencement.

Methods

Clients from 34 community-based AOD centres completed surveys on demographic, substance use, health-related quality of life and social characteristics. A linear mixed model and two negative binomial models were used to examine factors associated with higher AUDIT scores (indicting more hazardous or harmful alcohol consumption), frequency of drinking days and heavy drinking days in the last 14 days.

Results

Participants (n = 1130) were predominantly male (65%), reported concurrent drug use (62%), self-referred for treatment (57%) and wanted to cease alcohol use completely (42%) or drink moderately (39%). Female gender, unemployment, being a victim or perpetrator of violence, poorer physical and mental health, self-referral and a goal to cease alcohol use were associated with higher AUDIT scores. Those reporting home duties, retirement, disability/carer pension, student or other employment had lower AUDIT scores. Older age, poorer physical and mental health, and treatment in Western Australia and Queensland were associated with more drinking and heavier drinking days. A goal to cease alcohol use was linked to 23% and 17% lower drinking days and heavy drinking days. Self-referral was associated with more heavy drinking days.

Discussion and Conclusion

Individuals seeking treatment for AOD use have diverse needs that should inform tailored and holistic treatment.

前言:了解寻求酒精使用治疗的个体的特征对于制定有效的干预措施至关重要。本研究旨在:(i)描述在澳大利亚门诊酒精和其他药物(AOD)治疗中心接受治疗的个人特征;(二)确定在治疗开始时与更有害的酒精使用有关的特征。方法:来自34个社区AOD中心的患者完成了人口统计、物质使用、健康相关生活质量和社会特征的调查。使用线性混合模型和两个负二项模型来检查与较高的AUDIT分数(表明更危险或有害的酒精消费)、最近14天内饮酒天数频率和重度饮酒天数相关的因素。结果:参与者(n = 1130)主要是男性(65%),报告同时使用药物(62%),自我推荐治疗(57%),希望完全停止饮酒(42%)或适度饮酒(39%)。女性性别、失业、成为暴力受害者或施暴者、较差的身心健康、自我转诊和戒酒目标与较高的审计得分有关。那些报告家务、退休、残疾/照顾者养老金、学生或其他就业的人的审计得分较低。在西澳大利亚州和昆士兰州,年龄较大、身心健康状况较差以及治疗与饮酒次数和饮酒天数有关。戒酒的目标与饮酒天数和重度饮酒天数分别减少23%和17%有关。自我推荐与更多的酗酒天数有关。讨论与结论:寻求AOD治疗的个体有不同的需求,应该为定制和整体治疗提供信息。
{"title":"Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in Australia","authors":"Jamie Bryant,&nbsp;Anthony Shakeshaft,&nbsp;Nicholas Lintzeris,&nbsp;Paul Haber,&nbsp;Michael Farrell,&nbsp;Joshua Dizon,&nbsp;Megan Freund","doi":"10.1111/dar.70034","DOIUrl":"10.1111/dar.70034","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Understanding the characteristics of individuals seeking treatment for alcohol use is essential for developing effective interventions. This study aimed to: (i) describe the characteristics of individuals accessing treatment at Australian outpatient alcohol and other drug (AOD) treatment centres; and (ii) identify characteristics associated with more harmful alcohol use at treatment commencement.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Clients from 34 community-based AOD centres completed surveys on demographic, substance use, health-related quality of life and social characteristics. A linear mixed model and two negative binomial models were used to examine factors associated with higher AUDIT scores (indicting more hazardous or harmful alcohol consumption), frequency of drinking days and heavy drinking days in the last 14 days.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Participants (<i>n</i> = 1130) were predominantly male (65%), reported concurrent drug use (62%), self-referred for treatment (57%) and wanted to cease alcohol use completely (42%) or drink moderately (39%). Female gender, unemployment, being a victim or perpetrator of violence, poorer physical and mental health, self-referral and a goal to cease alcohol use were associated with higher AUDIT scores. Those reporting home duties, retirement, disability/carer pension, student or other employment had lower AUDIT scores. Older age, poorer physical and mental health, and treatment in Western Australia and Queensland were associated with more drinking and heavier drinking days. A goal to cease alcohol use was linked to 23% and 17% lower drinking days and heavy drinking days. Self-referral was associated with more heavy drinking days.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>Individuals seeking treatment for AOD use have diverse needs that should inform tailored and holistic treatment.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2066-2079"},"PeriodicalIF":2.6,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants 一氧化二氮的来源,使用和危害:从使用摇头丸/MDMA和其他非法兴奋剂的澳大利亚人的见解。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-03 DOI: 10.1111/dar.70032
Jodie Grigg, Simon Lenton, Amy Peacock, Jessamine Soderstrom, Cate King, Natalie Thomas, Rachel Sutherland

Introduction

Increasing harms associated with nitrous oxide use have raised concerns, but limited evidence exists to inform harm reduction. This study aimed to identify how nitrous oxide is sourced, the products/forms used, awareness of health risks, engagement in harm reduction and experience of neurological symptoms.

Methods

Data were collected via annual interviews (2021–2023) with cross-sectional convenience samples of Australians who regularly used ecstasy/MDMA and/or other illicit stimulants and reported past 6-month use of nitrous oxide (2021 n = 379; 2022 n = 315; 2023 n = 284).

Results

The most commonly reported source of nitrous oxide in the past 6 months was convenience stores, followed by 24/7 delivery services. Sourcing from these retailers was also associated with heavier use. Reported use of larger cylinders (> 8 g) increased from 6% in 2021 to 26% in 2023. While most respondents demonstrated awareness of neurological risk (e.g., brain damage 63%; nerve damage 20%), only one-fifth identified the risk of Vitamin B12 depletion and 17% were unaware of any risks. Almost one-third (30%) reported limiting use per session, 36% limited frequency and 36% took no precautions. Reports of neurological symptoms rose from 5% in 2021 to 14% in 2023 among cross-sectional samples, with few (n ≤ 5) receiving treatment.

Discussion and Conclusions

Findings suggest increasing use of larger cylinders, alongside increasing neurological harms. Given the evolving regulatory and risk environment, close surveillance of usage and market trends is needed. The findings reinforce the need for balanced regulation and targeted education of retailers, clinicians and consumers to reduce harmful patterns of use and encourage early intervention.

导言:与使用一氧化二氮相关的危害日益增加引起了人们的关注,但现有的减少危害的证据有限。这项研究旨在确定一氧化二氮的来源、使用的产品/形式、对健康风险的认识、参与减少危害和神经系统症状的经历。方法:通过年度访谈(2021-2023)收集数据,这些横断面方便样本是经常使用摇头丸/MDMA和/或其他非法兴奋剂并报告过去6个月使用一氧化二氮的澳大利亚人(2021 n = 379; 2022 n = 315; 2023 n = 284)。结果:过去6个月报告的一氧化二氮最常见的来源是便利店,其次是24/7送货服务。从这些零售商那里采购也与更频繁的使用有关。据报道,大气缸(bbb80 g)的使用率从2021年的6%增加到2023年的26%。虽然大多数受访者表示意识到神经系统风险(例如,脑损伤63%;神经损伤20%),但只有五分之一的人认识到维生素B12缺乏的风险,17%的人不知道任何风险。近三分之一(30%)的人报告限制每次使用,36%的人限制频率,36%的人没有采取预防措施。在横断面样本中,神经系统症状的报告从2021年的5%上升到2023年的14%,接受治疗的病例很少(n≤5)。讨论和结论:研究结果表明越来越多地使用更大的钢瓶,同时增加神经损伤。鉴于不断变化的监管和风险环境,需要密切监测使用情况和市场趋势。研究结果表明,有必要对零售商、临床医生和消费者进行平衡的监管和有针对性的教育,以减少有害的使用模式,并鼓励早期干预。
{"title":"Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants","authors":"Jodie Grigg,&nbsp;Simon Lenton,&nbsp;Amy Peacock,&nbsp;Jessamine Soderstrom,&nbsp;Cate King,&nbsp;Natalie Thomas,&nbsp;Rachel Sutherland","doi":"10.1111/dar.70032","DOIUrl":"10.1111/dar.70032","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Increasing harms associated with nitrous oxide use have raised concerns, but limited evidence exists to inform harm reduction. This study aimed to identify how nitrous oxide is sourced, the products/forms used, awareness of health risks, engagement in harm reduction and experience of neurological symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data were collected via annual interviews (2021–2023) with cross-sectional convenience samples of Australians who regularly used ecstasy/MDMA and/or other illicit stimulants and reported past 6-month use of nitrous oxide (2021 <i>n</i> = 379; 2022 <i>n</i> = 315; 2023 <i>n</i> = 284).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The most commonly reported source of nitrous oxide in the past 6 months was convenience stores, followed by 24/7 delivery services. Sourcing from these retailers was also associated with heavier use. Reported use of larger cylinders (&gt; 8 g) increased from 6% in 2021 to 26% in 2023. While most respondents demonstrated awareness of neurological risk (e.g., brain damage 63%; nerve damage 20%), only one-fifth identified the risk of Vitamin B12 depletion and 17% were unaware of any risks. Almost one-third (30%) reported limiting use per session, 36% limited frequency and 36% took no precautions. Reports of neurological symptoms rose from 5% in 2021 to 14% in 2023 among cross-sectional samples, with few (<i>n</i> ≤ 5) receiving treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Findings suggest increasing use of larger cylinders, alongside increasing neurological harms. Given the evolving regulatory and risk environment, close surveillance of usage and market trends is needed. The findings reinforce the need for balanced regulation and targeted education of retailers, clinicians and consumers to reduce harmful patterns of use and encourage early intervention.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2113-2126"},"PeriodicalIF":2.6,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normalisation of Non-Drinking and Implications for Psycho-Social Problems 不饮酒的正常化及其对心理社会问题的影响。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-03 DOI: 10.1111/dar.70031
Elin K. Bye, Ingeborg Rossow, Inger Synnøve Moan

Introduction

A few decades ago, non-drinking was uncommon amongst young people in many countries, and non-drinkers typically reported more psycho-social problems than moderate drinkers. Since then, non-drinking has become common amongst Norwegian adolescents. Considering this normalisation of non-drinking, our study examined: (i) whether psycho-social problems still differ between non-drinkers, moderate drinkers and heavy drinkers; and (ii) whether psycho-social problems differ by parental drinking status amongst non-drinkers and moderate drinkers.

Methods

Data stem from the European School Survey Project on Alcohol and Other Drugs (ESPAD). The Norwegian 2024 subsample included 3471 15–16-year-olds. Psycho-social problems included anxiety and depressive symptoms and weak social support from friends and family. Parental drinking status distinguished between families with at least one non-drinking parent and families where both parents were drinkers. Mean values of non-drinkers (46% of the sample) were compared to mean values of moderate (42%) and heavy drinkers (12%) using analysis of variance and F-tests.

Results

Compared to moderate drinkers, non-drinkers reported significantly fewer anxiety and depressive symptoms, and significantly better social support from family and friends, whereas heavy drinkers reported significantly more psycho-social problems. Amongst non-drinkers, there was no significant difference in psycho-social problems by parental drinking status. Amongst moderate drinkers, those with non-drinking parents reported significantly poorer support from friends and family than others.

Discussion and Conclusions

This study lent empirical support to the hypothesis that in a context of normalised non-drinking amongst adolescents, psycho-social deviance amongst non-drinkers is not observed.

几十年前,不饮酒在许多国家的年轻人中并不常见,不饮酒者通常比适度饮酒者报告更多的心理社会问题。从那时起,不喝酒在挪威青少年中变得很普遍。考虑到这种不饮酒的正常化,我们的研究检验了:(i)不饮酒者、适度饮酒者和重度饮酒者之间的心理社会问题是否仍然不同;(ii)不饮酒者和适度饮酒者的心理社会问题是否因父母饮酒状况而不同。方法:数据来自欧洲学校酒精和其他药物调查项目(ESPAD)。挪威2024个子样本包括3471名15-16岁的年轻人。心理社会问题包括焦虑和抑郁症状以及来自朋友和家人的社会支持不足。父母饮酒状况区分了父母中至少有一方不饮酒的家庭和父母双方都饮酒的家庭。使用方差分析和f检验将不饮酒者(占样本的46%)的平均值与中度饮酒者(42%)和重度饮酒者(12%)的平均值进行比较。结果:与适度饮酒者相比,不饮酒者报告的焦虑和抑郁症状明显减少,家庭和朋友的社会支持明显更好,而重度饮酒者报告的心理社会问题明显更多。在非饮酒者中,父母饮酒状况对社会心理问题的影响无显著差异。在适度饮酒者中,那些父母不喝酒的人从朋友和家人那里得到的支持明显少于其他人。讨论和结论:本研究为以下假设提供了实证支持:在青少年戒酒正常化的背景下,不喝酒的人的社会心理偏差没有被观察到。
{"title":"Normalisation of Non-Drinking and Implications for Psycho-Social Problems","authors":"Elin K. Bye,&nbsp;Ingeborg Rossow,&nbsp;Inger Synnøve Moan","doi":"10.1111/dar.70031","DOIUrl":"10.1111/dar.70031","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>A few decades ago, non-drinking was uncommon amongst young people in many countries, and non-drinkers typically reported more psycho-social problems than moderate drinkers. Since then, non-drinking has become common amongst Norwegian adolescents. Considering this normalisation of non-drinking, our study examined: (i) whether psycho-social problems still differ between non-drinkers, moderate drinkers and heavy drinkers; and (ii) whether psycho-social problems differ by parental drinking status amongst non-drinkers and moderate drinkers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data stem from the European School Survey Project on Alcohol and Other Drugs (ESPAD). The Norwegian 2024 subsample included 3471 15–16-year-olds. Psycho-social problems included anxiety and depressive symptoms and weak social support from friends and family. Parental drinking status distinguished between families with at least one non-drinking parent and families where both parents were drinkers. Mean values of non-drinkers (46% of the sample) were compared to mean values of moderate (42%) and heavy drinkers (12%) using analysis of variance and F-tests.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared to moderate drinkers, non-drinkers reported significantly fewer anxiety and depressive symptoms, and significantly better social support from family and friends, whereas heavy drinkers reported significantly more psycho-social problems. Amongst non-drinkers, there was no significant difference in psycho-social problems by parental drinking status. Amongst moderate drinkers, those with non-drinking parents reported significantly poorer support from friends and family than others.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>This study lent empirical support to the hypothesis that in a context of normalised non-drinking amongst adolescents, psycho-social deviance amongst non-drinkers is not observed.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2106-2112"},"PeriodicalIF":2.6,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol Promotion via User-Generated Content on Instagram and TikTok: A Content Analysis 通过Instagram和TikTok上的用户生成内容进行酒精促销:一项内容分析。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-02 DOI: 10.1111/dar.70027
Alessandro Crocetti, Nichole Lister, Florentine Martino, Jennifer Browne, Kathryn Backholer, Peter Miller, Emma Jane Pristov, Matthew Dunn

Introduction

Alcohol-related user-generated content (UGC)—created by influencers and peers—appears to play a central role in shaping young people's alcohol-related attitudes and behaviours. However, the nature and extent to which UGC facilitates the promotion of alcohol remains under-examined. There is limited evidence on how alcohol companies utilise social media platforms to engage users and incentivise the promotion of their brands and products. Therefore, this study aimed to examine the nature and extent of alcohol promotion via UGC on Instagram and TikTok posts.

Methods

This content analysis examined 1848 public user-generated Instagram (n = 1148) and TikTok (n = 700) posts, focusing on major alcohol tags and hashtags over a 7-year period. Posts were systematically coded for account type, sentiment, product placement and indicators of marketing (e.g., sponsorship or undisclosed marketing).

Results

Of the posts analysed, 37% originated from influencers accounts. Five percent were identified as sponsored content, while 10% showed characteristics of undisclosed marketing. Half featured alcohol as the main focus, with 64% including branded products. Most posts (78%) expressed pro-brand sentiment, 53% showed positive drinking experiences and 20% portrayed camaraderie. Only 2% contained anti-brand sentiment or depicted negative consequences of alcohol consumption.

Discussion and Conclusions

The disparity between disclosed (5%) and suspected undisclosed promotional content (10%) highlights transparency and regulatory issues. UGC predominantly carried a celebratory tone, reinforcing a pro-alcohol narrative that influences young users' attitudes towards drinking. Stronger regulatory frameworks, independent monitoring and content transparency tools are urgently needed to mitigate young people's exposure to covert alcohol promotion.

导言:由影响者和同龄人创建的与酒精有关的用户生成内容(UGC)似乎在塑造年轻人与酒精有关的态度和行为方面发挥着核心作用。然而,教资会协助推广酒类的性质和程度,仍有待检讨。关于酒类公司如何利用社交媒体平台吸引用户并激励其品牌和产品的推广,证据有限。因此,本研究旨在研究通过Instagram和TikTok帖子上的UGC进行酒精促销的性质和程度。方法:该内容分析检查了1848个公共用户生成的Instagram (n = 1148)和TikTok (n = 700)帖子,重点关注7年期间的主要酒精标签和话题标签。帖子根据账户类型、情绪、产品位置和营销指标(如赞助或未披露的营销)进行系统编码。结果:在分析的帖子中,37%来自网红账户。其中5%被认定为赞助内容,而10%则表现出未公开营销的特征。一半的人主要关注酒精,64%的人关注品牌产品。大多数帖子(78%)表达了支持品牌的情绪,53%的帖子表达了积极的饮酒体验,20%的帖子描绘了同志情谊。只有2%包含反品牌情绪或描述酒精消费的负面后果。讨论与结论:已披露(5%)和疑似未披露的促销内容(10%)之间的差异凸显了透明度和监管问题。UGC主要带有庆祝的语气,强化了支持饮酒的叙事,影响了年轻用户对饮酒的态度。迫切需要更强有力的监管框架、独立监测和内容透明度工具,以减少年轻人接触隐蔽的酒精促销。
{"title":"Alcohol Promotion via User-Generated Content on Instagram and TikTok: A Content Analysis","authors":"Alessandro Crocetti,&nbsp;Nichole Lister,&nbsp;Florentine Martino,&nbsp;Jennifer Browne,&nbsp;Kathryn Backholer,&nbsp;Peter Miller,&nbsp;Emma Jane Pristov,&nbsp;Matthew Dunn","doi":"10.1111/dar.70027","DOIUrl":"10.1111/dar.70027","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol-related user-generated content (UGC)—created by influencers and peers—appears to play a central role in shaping young people's alcohol-related attitudes and behaviours. However, the nature and extent to which UGC facilitates the promotion of alcohol remains under-examined. There is limited evidence on how alcohol companies utilise social media platforms to engage users and incentivise the promotion of their brands and products. Therefore, this study aimed to examine the nature and extent of alcohol promotion via UGC on Instagram and TikTok posts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This content analysis examined 1848 public user-generated Instagram (<i>n</i> = 1148) and TikTok (<i>n</i> = 700) posts, focusing on major alcohol tags and hashtags over a 7-year period. Posts were systematically coded for account type, sentiment, product placement and indicators of marketing (e.g., sponsorship or undisclosed marketing).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the posts analysed, 37% originated from influencers accounts. Five percent were identified as sponsored content, while 10% showed characteristics of undisclosed marketing. Half featured alcohol as the main focus, with 64% including branded products. Most posts (78%) expressed pro-brand sentiment, 53% showed positive drinking experiences and 20% portrayed camaraderie. Only 2% contained anti-brand sentiment or depicted negative consequences of alcohol consumption.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The disparity between disclosed (5%) and suspected undisclosed promotional content (10%) highlights transparency and regulatory issues. UGC predominantly carried a celebratory tone, reinforcing a pro-alcohol narrative that influences young users' attitudes towards drinking. Stronger regulatory frameworks, independent monitoring and content transparency tools are urgently needed to mitigate young people's exposure to covert alcohol promotion.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2019-2029"},"PeriodicalIF":2.6,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Residential Managed Alcohol Program for Aboriginal Peoples Experiencing Homelessness and Alcohol Dependence: Short-Term Impacts of an Australian Trial 对经历无家可归和酒精依赖的土著居民的住宅管理酒精计划的评估:澳大利亚试验的短期影响。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-09-02 DOI: 10.1111/dar.70025
Kirrilly Thompson, Gianluca Di Censo, Jacqueline Bowden, Neophytos Georgiou, Mark Thompson, Victoria Cock, Blaire Brewerton, Courtney Ryder

Introduction

Homelessness and alcohol dependence can be barriers to accessing essential services such as health care, housing, and social supports. Managed alcohol programs (MAP) have emerged as an effective harm reduction strategy for people experiencing homelessness and alcohol dependence. The aim of the present study was to evaluate the short-term impacts of the first MAP run in South Australia outside of COVID-19 restrictions and the first in Australia to be conducted in a healthcare setting. It was designed to be culturally appropriate for Aboriginal and Torres Strait Islander clients.

Methods

Descriptive quantitative analysis and an inductive content analysis of case notes for 21 clients who stayed at least one night in the South Australian MAP.

Results

Clients were mostly Aboriginal, female, of middle age and managing multiple health conditions. The median stay was 15 nights per client. The MAP contributed to client wellbeing broadly across five interconnected areas: culture, housing, medical support, government system navigation, and the building of capacity, resilience, and social connectedness.

Discussion and Conclusions

The South Australian MAP provided various interconnected short-term benefits relevant to people experiencing homelessness and alcohol dependence in general and Aboriginal peoples additionally experiencing the on-going impacts of colonisation in particular. This evaluation supports international literature on the value of MAPs as an effective harm reduction approach to co-occurring homelessness and alcohol dependence and strengthens evidence for the feasibility, acceptability, and benefits of MAPs in Australia.

导言:无家可归和酒精依赖可能成为获得保健、住房和社会支持等基本服务的障碍。酒精管理方案(MAP)已成为无家可归和酒精依赖者减少伤害的有效策略。本研究的目的是评估南澳大利亚州首次在COVID-19限制之外运行的MAP的短期影响,以及澳大利亚首次在医疗保健环境中进行的MAP。它的设计是为了适应原住民和托雷斯海峡岛民的文化需求。方法:采用描述性定量分析和归纳性内容分析的方法,对21名在南澳大利亚州MAP住宿至少一晚的患者的病例记录进行分析。结果:患者以原住民、女性、中年、多种健康状况为主。每位客户的平均住宿时间为15晚。MAP在五个相互关联的领域为客户福祉做出了广泛贡献:文化、住房、医疗支持、政府系统导航,以及能力建设、复原力和社会联系。讨论和结论:南澳大利亚MAP提供了各种相互关联的短期福利,这些福利与无家可归和普遍酗酒的人以及特别受到殖民化持续影响的土著人民有关。这一评价支持了国际文献关于MAPs作为一种有效减少无家可归和酒精依赖同时发生的危害的方法的价值,并加强了澳大利亚MAPs的可行性、可接受性和效益的证据。
{"title":"Evaluation of a Residential Managed Alcohol Program for Aboriginal Peoples Experiencing Homelessness and Alcohol Dependence: Short-Term Impacts of an Australian Trial","authors":"Kirrilly Thompson,&nbsp;Gianluca Di Censo,&nbsp;Jacqueline Bowden,&nbsp;Neophytos Georgiou,&nbsp;Mark Thompson,&nbsp;Victoria Cock,&nbsp;Blaire Brewerton,&nbsp;Courtney Ryder","doi":"10.1111/dar.70025","DOIUrl":"10.1111/dar.70025","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Homelessness and alcohol dependence can be barriers to accessing essential services such as health care, housing, and social supports. Managed alcohol programs (MAP) have emerged as an effective harm reduction strategy for people experiencing homelessness and alcohol dependence. The aim of the present study was to evaluate the short-term impacts of the first MAP run in South Australia outside of COVID-19 restrictions and the first in Australia to be conducted in a healthcare setting. It was designed to be culturally appropriate for Aboriginal and Torres Strait Islander clients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Descriptive quantitative analysis and an inductive content analysis of case notes for 21 clients who stayed at least one night in the South Australian MAP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Clients were mostly Aboriginal, female, of middle age and managing multiple health conditions. The median stay was 15 nights per client. The MAP contributed to client wellbeing broadly across five interconnected areas: culture, housing, medical support, government system navigation, and the building of capacity, resilience, and social connectedness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The South Australian MAP provided various interconnected short-term benefits relevant to people experiencing homelessness and alcohol dependence in general and Aboriginal peoples additionally experiencing the on-going impacts of colonisation in particular. This evaluation supports international literature on the value of MAPs as an effective harm reduction approach to co-occurring homelessness and alcohol dependence and strengthens evidence for the feasibility, acceptability, and benefits of MAPs in Australia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2061-2065"},"PeriodicalIF":2.6,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis 2022年欧盟和英国的酒精消费税、税收份额和收入:概述和建模分析。
IF 2.6 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2025-08-28 DOI: 10.1111/dar.70028
Jürgen Rehm, Daniela Correia, Ahmed S. Hassan, Jakob Manthey, Pol Rovira, Kevin D. Shield, Carina Ferreira-Borges, Maria Neufeld, Mindaugas Štelemėkas

Introduction

Although increases in alcohol excise taxation have been identified as one of the ‘best buys’ of the World Health Organization to reduce alcohol consumption and attributable harm, excise tax shares—the proportion of excise tax included in retail prices of alcoholic beverages—remain low in Europe. Revenue derived from alcohol excise taxation, and how it is affected by changes in alcohol excise taxation, has not yet been widely explored.

Methods

We conducted a search for revenues generated from alcohol excise taxation in all European Union (EU) countries and the United Kingdom between 2017 and 2022. We then calculated the average excise tax share for alcoholic beverages for 2022. Using regression analysis, we predict tax revenue per capita from the tax share, type of alcohol excise taxation, recorded and unrecorded consumption and prevalence of past-year drinking. To illustrate the potential for revenue increases, we conducted a case study on Germany.

Results

In 2022, average revenue from alcohol excise taxation (119 euros per capita) and excise tax share (17.3%) were low in the EU countries and the United Kingdom, but showed sizable variation. The association between excise tax share and revenue from excise taxation was very high, with a Pearson correlation of 0.888 (0.720–0.958; df = 16; p < 0.0001). In regression analyses, only the excise tax share significantly predicted tax revenue.

Discussion and Conclusions

Marked revenue gains could be achieved in several countries having low tax shares by instituting increases in excise tax share, with only small effects on consumer prices.

导言:虽然增加酒精消费税已被世界卫生组织确定为减少酒精消费和可归因于的危害的“最合算”措施之一,但消费税份额——酒精饮料零售价格中包含的消费税比例——在欧洲仍然很低。酒精消费税产生的收入,以及它如何受到酒精消费税变化的影响,尚未得到广泛探讨。方法:我们对2017年至2022年间所有欧盟(EU)国家和英国的酒精消费税收入进行了搜索。然后,我们计算了2022年酒精饮料的平均消费税份额。使用回归分析,我们从税收份额、酒精消费税类型、记录和未记录的消费量以及过去一年饮酒的流行程度来预测人均税收收入。为了说明收入增长的潜力,我们对德国进行了一个案例研究。结果:2022年,欧盟国家和英国的酒精消费税平均收入(人均119欧元)和消费税份额(17.3%)都很低,但差异很大。消费税份额和消费税收入之间的关联非常高,皮尔逊相关性为0.888 (0.720-0.958;df = 16; p)。讨论和结论:在几个税收份额低的国家,通过提高消费税份额可以实现显著的收入增长,对消费者价格的影响很小。
{"title":"Alcohol Excise Taxation, Tax Share and Revenue in the European Union and the United Kingdom in 2022: An Overview and Modelling Analysis","authors":"Jürgen Rehm,&nbsp;Daniela Correia,&nbsp;Ahmed S. Hassan,&nbsp;Jakob Manthey,&nbsp;Pol Rovira,&nbsp;Kevin D. Shield,&nbsp;Carina Ferreira-Borges,&nbsp;Maria Neufeld,&nbsp;Mindaugas Štelemėkas","doi":"10.1111/dar.70028","DOIUrl":"10.1111/dar.70028","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Although increases in alcohol excise taxation have been identified as one of the ‘best buys’ of the World Health Organization to reduce alcohol consumption and attributable harm, excise tax shares—the proportion of excise tax included in retail prices of alcoholic beverages—remain low in Europe. Revenue derived from alcohol excise taxation, and how it is affected by changes in alcohol excise taxation, has not yet been widely explored.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a search for revenues generated from alcohol excise taxation in all European Union (EU) countries and the United Kingdom between 2017 and 2022. We then calculated the average excise tax share for alcoholic beverages for 2022. Using regression analysis, we predict tax revenue per capita from the tax share, type of alcohol excise taxation, recorded and unrecorded consumption and prevalence of past-year drinking. To illustrate the potential for revenue increases, we conducted a case study on Germany.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In 2022, average revenue from alcohol excise taxation (119 euros per capita) and excise tax share (17.3%) were low in the EU countries and the United Kingdom, but showed sizable variation. The association between excise tax share and revenue from excise taxation was very high, with a Pearson correlation of 0.888 (0.720–0.958; df = 16; <i>p</i> &lt; 0.0001). In regression analyses, only the excise tax share significantly predicted tax revenue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Marked revenue gains could be achieved in several countries having low tax shares by instituting increases in excise tax share, with only small effects on consumer prices.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"44 7","pages":"2003-2012"},"PeriodicalIF":2.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug and alcohol review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1